,

Olaparib 150 mg Tablet for BRCA-mutated cancer treatment

0.00$

+ Free Shipping

Olaparib 150 mg Tablet (Olanib) is a targeted cancer therapy belonging to the PARP inhibitor class. It is used in the treatment of BRCA-mutated ovarian, breast, prostate, and pancreatic cancers by preventing cancer cells from repairing damaged DNA. Prescription use only.

Field Details
Brand Name Olanib
Generic Name Olaparib
Strength 150 mg
Pack Size 120 Tablets
Dosage Form Tablet (Oral)
Manufacturer Everest Pharmaceuticals Ltd.
Made in Bangladesh
Reference Brand Lynparza
Drug Class PARP Inhibitor
Primary Category Oncology Medicines
Secondary Category Ovarian Cancer Treatment
Therapeutic Category Targeted Cancer Therapy
Indication Ovarian Cancer, Breast Cancer, Prostate Cancer, Pancreatic Cancer (BRCA-mutated)
Guaranteed Safe Checkout

What is Olaparib 150 mg Tablet?

Olaparib 150 mg Tablet is an oral anti-cancer medicine used in the treatment of certain solid tumors associated with BRCA gene mutations. It belongs to the class of PARP inhibitors, which work by preventing cancer cells from repairing their damaged DNA, leading to cancer cell death.

Olanib is a generic formulation of olaparib and is therapeutically equivalent to the reference brand Lynparza.


Uses of Olaparib 150 mg Tablet

Olaparib 150 mg Tablet is prescribed for adult patients with:

Ovarian Cancer

  • BRCA-mutated advanced ovarian cancer

  • Maintenance therapy after response to chemotherapy

Breast Cancer

  • HER2-negative, BRCA-mutated metastatic breast cancer

Prostate Cancer

  • Metastatic castration-resistant prostate cancer with BRCA mutation

Pancreatic Cancer

  • BRCA-mutated metastatic pancreatic cancer


How Olaparib Works

Olaparib blocks the activity of poly (ADP-ribose) polymerase (PARP) enzymes.

Mechanism of Action

  • Inhibits DNA repair in cancer cells

  • Causes accumulation of DNA damage

  • Leads to selective cancer cell death


Dosage and Administration

Dosage and treatment duration must be determined by an oncologist.

Administration Guidelines

  • Taken orally as prescribed

  • Can be taken with or without food

  • Tablets should be swallowed whole

Do not change the dose or discontinue therapy without medical advice.


Possible Side Effects

Side effects may vary depending on patient condition and treatment duration.

Common Side Effects

  • Nausea

  • Fatigue

  • Anemia

  • Loss of appetite

Less Common Side Effects

  • Vomiting

  • Diarrhea

  • Low white blood cell count

Consult your doctor if side effects persist or worsen.


Warnings and Precautions

Olaparib should be used under specialist supervision.

Important Safety Information

  • Prescription-only oncology medicine

  • Regular blood count monitoring required

  • Not recommended during pregnancy or breastfeeding

  • Genetic testing for BRCA mutation is required


Storage Instructions

Proper Storage

  • Store below 30°C

  • Protect from moisture and light

  • Keep out of reach of children


Frequently Asked Questions

What is Olaparib 150 mg Tablet used for?

It is used to treat BRCA-mutated ovarian, breast, prostate, and pancreatic cancers.

Is Olaparib chemotherapy?

No. It is a targeted therapy, not traditional chemotherapy.

Is BRCA testing mandatory?

Yes, BRCA mutation testing is required before starting treatment.

Can Olaparib be taken long term?

Yes, under oncologist supervision and regular monitoring.

Product Categories

  • Oncology Medicines

  • Targeted Cancer Therapy

  • Ovarian Cancer Treatment

  • Breast Cancer Treatment

Let's chat